GlaxoSmithKline And Adolor Report Favourable FDA Advisory Committee Meeting For Entereg For The Management Of ... (Medical News Today)
GlaxoSmithKline and Adolor Corporation (Nasdaq: ADLR) announced that a majority (9-6) of the Gastrointestinal Drugs Advisory Committee (GIDAC) of the U.S.

Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application To U.S. ... (Medical News Today)
Velcura Therapeutics Inc., an early stage biotechnology company developing therapies for bone disease, recently completed a successful Investigational New Drug application (IND) to the U.S. Food and Drug Administration (FDA). The IND enables Velcura to proceed with the first-in-man clinical trials for its lead compound, VEL-0230.

Medivation Plans To Initiate Pivotal Confirmatory Phase 3 Trial Of Dimebon(TM) For Alzheimer's Disease In Second ... (Medical News Today)
Medivation, Inc. (Nasdaq: MDVN) announced that, based on its end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA), the Company plans to begin a pivotal confirmatory Phase 3 trial of Dimebon(TM) for mild-to-moderate Alzheimer's Disease in the second quarter of 2008.